AMARANTUS BIOSCIEN (AMBS)

0.08
0.01 8.03
OTC
Prev Close 0.09
Open 0.09
Day Low/High 0.08 / 0.09
52 Wk Low/High 0.01 / 0.21
Volume 122.25K
Exchange OTC
Shares Outstanding 68.27B
Market Cap 6.01M
Div & Yield N.A. (N.A)

Latest News

Amarantus Subsidiary Elto Pharma Receives Notice Of Allowance For European Patent Application Covering Method Of Treating Cognitive Impairment Associated With Alzheimer's Disease And Parkinson's Disease With Eltoprazine

Amarantus Subsidiary Elto Pharma Receives Notice Of Allowance For European Patent Application Covering Method Of Treating Cognitive Impairment Associated With Alzheimer's Disease And Parkinson's Disease With Eltoprazine

Once Issued, patent extends coverage for Eltoprazine in Europe into 2029 CEO to present at RedChip's Global Online Growth Conference on December 7, 2017

Amarantus Appoints Curtis Scribner, MD MBA As Sr. Vice President Of Regulatory Affairs

Amarantus Appoints Curtis Scribner, MD MBA As Sr. Vice President Of Regulatory Affairs

Dr. Scribner to Focus on Accelerated Regulatory Pathway for ESS

Amarantus To Present At The 2015 Aegis Growth Conference

Amarantus To Present At The 2015 Aegis Growth Conference

- Presentation and Live Webcast on October 9, 2015 at 11:25 a.m. PDT -

Amarantus Closes $5.5 Million Capital Infusion Through The Issuance Of A Combination Of Preferred Stock And Secured Debt Convertible

Amarantus Closes $5.5 Million Capital Infusion Through The Issuance Of A Combination Of Preferred Stock And Secured Debt Convertible

Company Simultaneously Repurchases All Outstanding Series G Convertible Preferred Stock